Shares of Community Health Systems Inc. (NYSE:CYH) dropped 4.2% during trading on Tuesday . The company traded as low as $12.72 and last traded at $12.74, with a volume of 1,067,400 shares trading hands. The stock had previously closed at $13.30.

CYH has been the subject of a number of recent analyst reports. Oppenheimer Holdings Inc. restated a “buy” rating on shares of Community Health Systems in a research report on Tuesday, May 3rd. Barclays PLC reduced their target price on shares of Community Health Systems from $32.00 to $29.00 and set an “equal weight” rating for the company in a research note on Wednesday, June 1st. Bank of America Corp. reaffirmed a “hold” rating and issued a $19.00 target price on shares of Community Health Systems in a research note on Wednesday, March 23rd. Robert W. Baird reaffirmed a “hold” rating on shares of Community Health Systems in a research note on Wednesday, March 23rd. Finally, Morgan Stanley reaffirmed a “hold” rating and issued a $18.00 target price on shares of Community Health Systems in a research note on Wednesday, March 23rd. Seven analysts have rated the stock with a sell rating, fourteen have assigned a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Community Health Systems has a consensus rating of “Hold” and an average target price of $23.63.

The company has a 50-day moving average of $13.15 and a 200 day moving average of $14.73. The firm has a market cap of $1.49 billion and a P/E ratio of 16.89.

Community Health Systems (NYSE:CYH) last released its quarterly earnings results on Monday, May 2nd. The company reported $0.27 earnings per share for the quarter, missing the consensus estimate of $0.74 by $0.47. The company had revenue of $5 billion for the quarter, compared to analyst estimates of $5.01 billion. During the same quarter in the previous year, the business posted $0.85 EPS. Equities analysts predict that Community Health Systems Inc. will post $2.24 EPS for the current fiscal year.

In related news, Director H Mitchell Watson, Jr. sold 5,600 shares of the business’s stock in a transaction dated Monday, June 13th. The shares were sold at an average price of $13.42, for a total transaction of $75,152.00. Following the transaction, the director now directly owns 6,509 shares in the company, valued at $87,350.78. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website.

A number of hedge funds and institutional investors recently added to or reduced their stakes in CYH. Russell Frank Co boosted its position in Community Health Systems by 85.5% in the fourth quarter. Russell Frank Co now owns 340,961 shares of the company’s stock worth $9,018,000 after buying an additional 157,136 shares during the last quarter. Neuberger Berman Group LLC bought a new position in Community Health Systems during the fourth quarter worth $1,617,000. Rhumbline Advisers boosted its position in Community Health Systems by 0.7% in the fourth quarter. Rhumbline Advisers now owns 174,096 shares of the company’s stock worth $4,619,000 after buying an additional 1,274 shares during the last quarter. California Public Employees Retirement System boosted its position in Community Health Systems by 47.0% in the fourth quarter. California Public Employees Retirement System now owns 540,496 shares of the company’s stock worth $14,339,000 after buying an additional 172,700 shares during the last quarter. Finally, Shell Asset Management Co. bought a new position in Community Health Systems during the fourth quarter worth $1,188,000.

Community Health Systems, Inc is a hospital company and an operator of acute care hospitals in communities across the United States. The Company provides healthcare services through the hospitals that it owns and operates in non-urban and selected urban markets throughout the United States. It operates in two operating segments: hospital operations and home care agencies operations.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.